Cite
St Denis JD, Hall RJ, Murray CW, et al. Fragment-based drug discovery: opportunities for organic synthesis. RSC Med Chem. 2020;12(3):321-329doi: 10.1039/d0md00375a.
St Denis, J. D., Hall, R. J., Murray, C. W., Heightman, T. D., & Rees, D. C. (2020). Fragment-based drug discovery: opportunities for organic synthesis. RSC medicinal chemistry, 12(3), 321-329. https://doi.org/10.1039/d0md00375a
St Denis, Jeffrey D, et al. "Fragment-based drug discovery: opportunities for organic synthesis." RSC medicinal chemistry vol. 12,3 (2020): 321-329. doi: https://doi.org/10.1039/d0md00375a
St Denis JD, Hall RJ, Murray CW, Heightman TD, Rees DC. Fragment-based drug discovery: opportunities for organic synthesis. RSC Med Chem. 2020 Dec 24;12(3):321-329. doi: 10.1039/d0md00375a. PMID: 34041484; PMCID: PMC8130625.
Copy
Download .nbib